메뉴 건너뛰기




Volumn 11, Issue 5, 2015, Pages 617-636

Efficacy of immunotherapy with mesenchymal stem cells in man: A systematic review

Author keywords

Organ transplantation

Indexed keywords

C PEPTIDE; CD27 ANTIGEN; CREATININE; GAMMA INTERFERON; HEMOGLOBIN; INSULIN; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; STROMAL CELL DERIVED FACTOR 1ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

EID: 84928188327     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/1744666X.2015.1029458     Document Type: Review
Times cited : (25)

References (85)
  • 1
    • 0033515827 scopus 로고    scopus 로고
    • Multilineage potential of adult human mesenchymal stem cells
    • Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284(5411):143-7
    • (1999) Science , vol.284 , Issue.5411 , pp. 143-147
    • Pittenger, M.F.1    MacKay, A.M.2    Beck, S.C.3
  • 2
    • 0037093058 scopus 로고    scopus 로고
    • Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
    • Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002;99(10):3838-43
    • (2002) Blood , vol.99 , Issue.10 , pp. 3838-3843
    • Di Nicola, M.1    Carlo-Stella, C.2    Magni, M.3
  • 3
    • 84923217704 scopus 로고    scopus 로고
    • Human adipose tissue-derived mesenchymal stem cells abrogate plasmablast formation and induce regulatory B cells independently of T helper cells
    • Franquesa M, Mensah FK, Huizinga R, et al. Human adipose tissue-derived mesenchymal stem cells abrogate plasmablast formation and induce regulatory B cells independently of T helper cells. Stem Cells 2015;33(3):880-91
    • (2015) Stem Cells , vol.33 , Issue.3 , pp. 880-891
    • Franquesa, M.1    Mensah, F.K.2    Huizinga, R.3
  • 4
    • 77949537626 scopus 로고    scopus 로고
    • Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile
    • Maggini J, Mirkin G, Bognanni I, et al. Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One 2010;5(2):e9252
    • (2010) PLoS One , vol.5 , Issue.2 , pp. e9252
    • Maggini, J.1    Mirkin, G.2    Bognanni, I.3
  • 5
    • 60449100851 scopus 로고    scopus 로고
    • Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses
    • Gonzalez MA, Gonzalez-Rey E, Rico L, et al. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 2009;136(3): 978-89
    • (2009) Gastroenterology , vol.136 , Issue.3 , pp. 978-989
    • Gonzalez, M.A.1    Gonzalez-Rey, E.2    Rico, L.3
  • 6
    • 58149326737 scopus 로고    scopus 로고
    • Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production
    • Nemeth K, Leelahavanichkul A, Yuen PS, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009;15(1):42-9
    • (2009) Nat Med , vol.15 , Issue.1 , pp. 42-49
    • Nemeth, K.1    Leelahavanichkul, A.2    Yuen, P.S.3
  • 7
    • 70350212973 scopus 로고    scopus 로고
    • Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis
    • Constantin G, Marconi S, Rossi B, et al. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells 2009;27(10):2624-35
    • (2009) Stem Cells , vol.27 , Issue.10 , pp. 2624-2635
    • Constantin, G.1    Marconi, S.2    Rossi, B.3
  • 8
    • 56049100237 scopus 로고    scopus 로고
    • Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate
    • Popp FC, Eggenhofer E, Renner P, et al. Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate. Transpl Immunol 2008; 20(1-2):55-60
    • (2008) Transpl Immunol , vol.20 , Issue.1-2 , pp. 55-60
    • Popp, F.C.1    Eggenhofer, E.2    Renner, P.3
  • 9
    • 84865355509 scopus 로고    scopus 로고
    • Safety and efficacy of mesenchymal stromal cell therapy in autoimmune disorders
    • Bernardo ME, Fibbe WE. Safety and efficacy of mesenchymal stromal cell therapy in autoimmune disorders. Ann N Y Acad Sci 2012;1266:107-17
    • (2012) Ann N y Acad Sci , vol.1266 , pp. 107-117
    • Bernardo, M.E.1    Fibbe, W.E.2
  • 10
    • 84881612444 scopus 로고    scopus 로고
    • Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Fourth Meeting: Lessons learned from first clinical trials
    • Franquesa M, Hoogduijn MJ, Reinders ME, et al. Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Fourth Meeting: lessons learned from first clinical trials. Transplantation 2013;96(3):234-8
    • (2013) Transplantation , vol.96 , Issue.3 , pp. 234-238
    • Franquesa, M.1    Hoogduijn, M.J.2    Reinders, M.E.3
  • 11
    • 2342482526 scopus 로고    scopus 로고
    • Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
    • Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363(9419):1439-41
    • (2004) Lancet , vol.363 , Issue.9419 , pp. 1439-1441
    • Le Blanc, K.1    Rasmusson, I.2    Sundberg, B.3
  • 12
    • 84868091993 scopus 로고    scopus 로고
    • Safety of cell therapy with mesenchymal stromal cells (SafeCell): A systematic review and meta-analysis of clinical trials
    • Lalu MM, McIntyre L, Pugliese C, et al. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One 2012;7(10):e47559
    • (2012) PLoS One , vol.7 , Issue.10 , pp. e47559
    • Lalu, M.M.1    McIntyre, L.2    Pugliese, C.3
  • 15
    • 84878567330 scopus 로고    scopus 로고
    • Efficacy and safety of mesenchymal stromal cell treatment from related donors for patients with refractory aplastic anemia
    • Xiao Y, Jiang ZJ, Pang Y, et al. Efficacy and safety of mesenchymal stromal cell treatment from related donors for patients with refractory aplastic anemia. Cytotherapy 2013;15(7):760-6
    • (2013) Cytotherapy , vol.15 , Issue.7 , pp. 760-766
    • Xiao, Y.1    Jiang, Z.J.2    Pang, Y.3
  • 16
    • 79951679002 scopus 로고    scopus 로고
    • Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation
    • Bernardo ME, Ball LM, Cometa AM, et al. Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation. Bone Marrow Transplant 2011;46(2):200-7
    • (2011) Bone Marrow Transplant , vol.46 , Issue.2 , pp. 200-207
    • Bernardo, M.E.1    Ball, L.M.2    Cometa, A.M.3
  • 17
    • 77952584405 scopus 로고    scopus 로고
    • Cotransplantation of Mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without Abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning
    • Baron F, Lechanteur C, Willems E, et al. Cotransplantation of Mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without Abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. Biol Blood Marrow Transplant 2010;16(6): 838-47
    • (2010) Biol Blood Marrow Transplant , vol.16 , Issue.6 , pp. 838-847
    • Baron, F.1    Lechanteur, C.2    Willems, E.3
  • 18
    • 34948892668 scopus 로고    scopus 로고
    • Cotransplantation of ex vivo-expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation
    • Ball LM, Bernardo ME, Roelofs H, et al. Cotransplantation of ex vivo-expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood 2007;110(7):2764-7
    • (2007) Blood , vol.110 , Issue.7 , pp. 2764-2767
    • Ball, L.M.1    Bernardo, M.E.2    Roelofs, H.3
  • 19
    • 84878619923 scopus 로고    scopus 로고
    • A placebo-controlled, randomized trial of mesenchymal stem cells in COPD
    • Weiss DJ, Casaburi R, Flannery R, et al. A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. Chest 2013;143(6):1590-8
    • (2013) Chest , vol.143 , Issue.6 , pp. 1590-1598
    • Weiss, D.J.1    Casaburi, R.2    Flannery, R.3
  • 20
    • 84875876271 scopus 로고    scopus 로고
    • Long term effects of the implantation of Wharton's jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus
    • Hu J, Yu X, Wang Z, et al. Long term effects of the implantation of Wharton's jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus. Endocr J 2013; 60(3):347-57
    • (2013) Endocr J , vol.60 , Issue.3 , pp. 347-357
    • Hu, J.1    Yu, X.2    Wang, Z.3
  • 21
    • 84883375670 scopus 로고    scopus 로고
    • Alterations in the cellular immune compartment of patients treated with third-party mesenchymal stromal cells following allogeneic hematopoietic stem cell transplantation
    • Jitschin R, Mougiakakos D, Von Bahr L, et al. Alterations in the cellular immune compartment of patients treated with third-party mesenchymal stromal cells following allogeneic hematopoietic stem cell transplantation. Stem Cells 2013;31(8): 1715-25
    • (2013) Stem Cells , vol.31 , Issue.8 , pp. 1715-1725
    • Jitschin, R.1    Mougiakakos, D.2    Von Bahr, L.3
  • 22
    • 84863049034 scopus 로고    scopus 로고
    • Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients
    • Zhang Z, Lin H, Shi M, et al. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J Gastroenterol Hepatol 2012;27(Suppl 2): 112-20
    • (2012) J Gastroenterol Hepatol , vol.27 , pp. 112-120
    • Zhang, Z.1    Lin, H.2    Shi, M.3
  • 23
    • 84876510973 scopus 로고    scopus 로고
    • Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients
    • Shi M, Zhang Z, Xu RN, et al. Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients. Stem Cells Transl Med 2012;1(10):725-31
    • (2012) Stem Cells Transl Med , vol.1 , Issue.10 , pp. 725-731
    • Shi, M.1    Zhang, Z.2    Xu, R.N.3
  • 24
    • 43049103438 scopus 로고    scopus 로고
    • Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study
    • Le Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008;371(9624):1579-86
    • (2008) Lancet , vol.371 , Issue.9624 , pp. 1579-1586
    • Le Blanc, K.1    Frassoni, F.2    Ball, L.3
  • 25
    • 84893145125 scopus 로고    scopus 로고
    • Mesenchymal stem cells versus mesenchymal stem cells combined with cord blood for engraftment failure after autologous hematopoietic stem cell transplantation: A pilot prospective, open-label, randomized trial
    • Xiong YY, Fan Q, Huang F, et al. Mesenchymal stem cells versus mesenchymal stem cells combined with cord blood for engraftment failure after autologous hematopoietic stem cell transplantation: a pilot prospective, open-label, randomized trial. Biol Blood Marrow Transplant 2014; 20(2):236-42
    • (2014) Biol Blood Marrow Transplant , vol.20 , Issue.2 , pp. 236-242
    • Xiong, Y.Y.1    Fan, Q.2    Huang, F.3
  • 26
    • 77955509074 scopus 로고    scopus 로고
    • Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population
    • Lucchini G, Introna M, Dander E, et al. Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population. Biol Blood Marrow Transplant 2010;16(9):1293-301
    • (2010) Biol Blood Marrow Transplant , vol.16 , Issue.9 , pp. 1293-1301
    • Lucchini, G.1    Introna, M.2    Dander, E.3
  • 27
    • 84896710813 scopus 로고    scopus 로고
    • Treatment of graft versus host disease with mesenchymal stromal cells: A phase i study on 40 adult and pediatric patients
    • Introna M, Lucchini G, Dander E, et al. Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients. Biol Blood Marrow Transplant 2014;20(3): 375-81
    • (2014) Biol Blood Marrow Transplant , vol.20 , Issue.3 , pp. 375-381
    • Introna, M.1    Lucchini, G.2    Dander, E.3
  • 28
    • 84906966129 scopus 로고    scopus 로고
    • Improvement in poor graft function after allogeneic hematopoietic stem cell transplantation upon administration of mesenchymal stem cells from third-party donors: A pilot prospective study
    • Liu X, Wu M, Peng Y, et al. Improvement in poor graft function after allogeneic hematopoietic stem cell transplantation upon administration of mesenchymal stem cells from third-party donors: a pilot prospective study. Cell Transplant 2014; 23(9):1087-98
    • (2014) Cell Transplant , vol.23 , Issue.9 , pp. 1087-1098
    • Liu, X.1    Wu, M.2    Peng, Y.3
  • 29
    • 84882246890 scopus 로고    scopus 로고
    • Unrelated allogeneic bone marrow-derived mesenchymal stem cells for steroid-refractory acute graft-versus-host disease: A phase I/II study
    • Muroi K, Miyamura K, Ohashi K, et al. Unrelated allogeneic bone marrow-derived mesenchymal stem cells for steroid-refractory acute graft-versus-host disease: a phase I/II study. Int J Hematol 2013;98(2):206-13
    • (2013) Int J Hematol , vol.98 , Issue.2 , pp. 206-213
    • Muroi, K.1    Miyamura, K.2    Ohashi, K.3
  • 30
    • 79952624644 scopus 로고    scopus 로고
    • Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal (trademark)) in Pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study
    • Prasad VK, Lucas KG, Kleiner GI, et al. Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal (trademark)) in Pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study. Biol Blood Marrow Transplant 2011;17(4): 534-41
    • (2011) Biol Blood Marrow Transplant , vol.17 , Issue.4 , pp. 534-541
    • Prasad, V.K.1    Lucas, K.G.2    Kleiner, G.I.3
  • 31
    • 67149093649 scopus 로고    scopus 로고
    • Adult Human Mesenchymal Stem Cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease
    • Kebriaei P, Isola L, Bahceci E, et al. Adult Human Mesenchymal Stem Cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. Biol Blood Marrow Transplant 2009;15(7):804-11
    • (2009) Biol Blood Marrow Transplant , vol.15 , Issue.7 , pp. 804-811
    • Kebriaei, P.1    Isola, L.2    Bahceci, E.3
  • 32
    • 67649859227 scopus 로고    scopus 로고
    • A modified haploidentical nonmyeloablative transplantation without t cell depletion for high-risk acute leukemia: Successful engraftment and mild GVHD
    • Guo M, Sun Z, Sun QY, et al. a modified haploidentical nonmyeloablative transplantation without t cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD. Biol Blood Marrow Transplant 2009;15(8):930-7
    • (2009) Biol Blood Marrow Transplant , vol.15 , Issue.8 , pp. 930-937
    • Guo, M.1    Sun, Z.2    Sun, Q.Y.3
  • 33
    • 20244389227 scopus 로고    scopus 로고
    • Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients
    • Lazarus HM, Koc ON, Devine SM, et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005;11(5):389-98
    • (2005) Biol Blood Marrow Transplant , vol.11 , Issue.5 , pp. 389-398
    • Lazarus, H.M.1    Koc, O.N.2    Devine, S.M.3
  • 34
    • 84899563126 scopus 로고    scopus 로고
    • Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: A multicenter clinical study
    • Wang D, Li J, Zhang Y, et al. Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: A multicenter clinical study. Arthritis Res Ther 2014;16:2
    • (2014) Arthritis Res Ther , vol.16 , pp. 2
    • Wang, D.1    Li, J.2    Zhang, Y.3
  • 35
    • 84890190232 scopus 로고    scopus 로고
    • A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy
    • Forbes GM, Sturm MJ, Leong RW, et al. A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy. Clin Gastroenterol Hepatol 2014;12(1):64-71
    • (2014) Clin Gastroenterol Hepatol , vol.12 , Issue.1 , pp. 64-71
    • Forbes, G.M.1    Sturm, M.J.2    Leong, R.W.3
  • 36
    • 84893106561 scopus 로고    scopus 로고
    • Allogeneic human mesenchymal stem cell therapy (Remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients
    • Kurtzberg J, Prockop S, Teira P, et al. Allogeneic human mesenchymal stem cell therapy (Remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients. Biol Blood Marrow Transplant 2014;20(2): 229-35
    • (2014) Biol Blood Marrow Transplant , vol.20 , Issue.2 , pp. 229-235
    • Kurtzberg, J.1    Prockop, S.2    Teira, P.3
  • 37
    • 84885826097 scopus 로고    scopus 로고
    • Gastrointestinal acute graft-versus-host disease in children: Histology for diagnosis, mesenchymal stromal cells for treatment, and biomarkers for prediction of response
    • Calkoen FGJ, Jol-van der Zijde CM, Mearin ML, et al. Gastrointestinal acute graft-versus-host disease in children: histology for diagnosis, mesenchymal stromal cells for treatment, and biomarkers for prediction of response. Biol Blood Marrow Transplant 2013;19(11):1590-9
    • (2013) Biol Blood Marrow Transplant , vol.19 , Issue.11 , pp. 1590-1599
    • Calkoen, F.G.J.1    Jol-Van Der Zijde, C.M.2    Mearin, M.L.3
  • 38
    • 84907440929 scopus 로고    scopus 로고
    • Co-infusion of donor adipose tissue-derived mesenchymal and hematopoietic stem cells helps safe minimization of immunosuppression in renal transplantation-Single center experience
    • Vanikar AV, Trivedi HL, Kumar A, et al. Co-infusion of donor adipose tissue-derived mesenchymal and hematopoietic stem cells helps safe minimization of immunosuppression in renal transplantation-single center experience. Ren Fail 2014; 36(9):1376-84
    • (2014) Ren Fail , vol.36 , Issue.9 , pp. 1376-1384
    • Vanikar, A.V.1    Trivedi, H.L.2    Kumar, A.3
  • 39
    • 84893008711 scopus 로고    scopus 로고
    • Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC)
    • Resnick IB, Barkats C, Shapira MY, et al. Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC). Am J Blood Res 2013;3(3):225-38
    • (2013) Am J Blood Res , vol.3 , Issue.3 , pp. 225-238
    • Resnick, I.B.1    Barkats, C.2    Shapira, M.Y.3
  • 40
    • 84924614444 scopus 로고    scopus 로고
    • Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10
    • Peng Y, Chen X, Liu Q, et al. Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10. Leukemia 2015;29(3):636-46
    • (2015) Leukemia , vol.29 , Issue.3 , pp. 636-646
    • Peng, Y.1    Chen, X.2    Liu, Q.3
  • 41
    • 84870606505 scopus 로고    scopus 로고
    • Mesenchymal stromal cells treatment attenuates dry eye in patients with chronic graft-versus-host disease
    • Weng J, He C, Lai P, et al. Mesenchymal stromal cells treatment attenuates dry eye in patients with chronic graft-versus-host disease. Mol Ther 2012;20(12):2347-54
    • (2012) Mol Ther , vol.20 , Issue.12 , pp. 2347-2354
    • Weng, J.1    He, C.2    Lai, P.3
  • 42
    • 33744913533 scopus 로고    scopus 로고
    • Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease
    • Ringden O, Uzunel M, Rasmusson I, et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006;81(10):1390-7
    • (2006) Transplantation , vol.81 , Issue.10 , pp. 1390-1397
    • Ringden, O.1    Uzunel, M.2    Rasmusson, I.3
  • 43
    • 84886675301 scopus 로고    scopus 로고
    • Cotransplantation of haploidentical hematopoietic and umbilical cord mesenchymal stem cells for severe aplastic anemia: Successful engraftment and mild GVHD
    • Wu Y, Cao Y, Li X, et al. Cotransplantation of haploidentical hematopoietic and umbilical cord mesenchymal stem cells for severe aplastic anemia: successful engraftment and mild GVHD. Stem Cell Res 2014;12(1):132-8
    • (2014) Stem Cell Res , vol.12 , Issue.1 , pp. 132-138
    • Wu, Y.1    Cao, Y.2    Li, X.3
  • 44
    • 84888127420 scopus 로고    scopus 로고
    • Cotransplantation of haploidentical hematopoietic and umbilical cord mesenchymal stem cells with a myeloablative regimen for refractory/ relapsed hematologic malignancy
    • Wu Y, Wang Z, Cao Y, et al. Cotransplantation of haploidentical hematopoietic and umbilical cord mesenchymal stem cells with a myeloablative regimen for refractory/ relapsed hematologic malignancy. Ann Hematol 2013;92(12):1675-84
    • (2013) Ann Hematol , vol.92 , Issue.12 , pp. 1675-1684
    • Wu, Y.1    Wang, Z.2    Cao, Y.3
  • 45
    • 80053422428 scopus 로고    scopus 로고
    • Coinfusion of mesenchymal stromal cells facilitates platelet recovery without increasing leukemia recurrence in haploidentical hematopoietic stem cell transplantation: A randomized, controlled clinical study
    • Liu K, Chen Y, Zeng Y, et al. Coinfusion of mesenchymal stromal cells facilitates platelet recovery without increasing leukemia recurrence in haploidentical hematopoietic stem cell transplantation: a randomized, controlled clinical study. Stem Cells Dev 2011;20(10):1679-85
    • (2011) Stem Cells Dev , vol.20 , Issue.10 , pp. 1679-1685
    • Liu, K.1    Chen, Y.2    Zeng, Y.3
  • 46
    • 40749112327 scopus 로고    scopus 로고
    • The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: Outcome of a pilot clinical study
    • Ning H, Yang F, Jiang M, et al. The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study. Leukemia 2008;22(3):593-9
    • (2008) Leukemia , vol.22 , Issue.3 , pp. 593-599
    • Ning, H.1    Yang, F.2    Jiang, M.3
  • 47
    • 79955853222 scopus 로고    scopus 로고
    • Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease
    • Ciccocioppo R, Bernardo ME, Sgarella A, et al. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease. Gut 2011; 60(6):788-98
    • (2011) Gut , vol.60 , Issue.6 , pp. 788-798
    • Ciccocioppo, R.1    Bernardo, M.E.2    Sgarella, A.3
  • 48
    • 80052024072 scopus 로고    scopus 로고
    • Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short-term and long-term outcomes
    • Peng L, Xie D, Lin BL, et al. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes. Hepatology 2011;54: 820-8
    • (2011) Hepatology , vol.54 , pp. 820-828
    • Peng, L.1    Xie, D.2    Lin, B.L.3
  • 49
    • 84872090856 scopus 로고    scopus 로고
    • Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: A clinical pilot study
    • Peng Y, Ke M, Xu L, et al. Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study. Transplantation 2013;95(1):161-8
    • (2013) Transplantation , vol.95 , Issue.1 , pp. 161-168
    • Peng, Y.1    Ke, M.2    Xu, L.3
  • 50
    • 84904893413 scopus 로고    scopus 로고
    • Randomized trial of autologous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis: Regulation of Treg/Th17 cells
    • Xu LM, Gong YW, Wang BF, et al. Randomized trial of autologous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis: regulation of Treg/Th17 cells. J Gastroenterol Hepatol 2014;29(8):1620-8
    • (2014) J Gastroenterol Hepatol , vol.29 , Issue.8 , pp. 1620-1628
    • Xu, L.M.1    Gong, Y.W.2    Wang, B.F.3
  • 51
    • 84881489447 scopus 로고    scopus 로고
    • Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study
    • Amin MA, Sabry D, Rashed LA, et al. Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study. Clin Transplant 2013;27(4):607-12
    • (2013) Clin Transplant , vol.27 , Issue.4 , pp. 607-612
    • Amin, M.A.1    Sabry, D.2    Rashed, L.A.3
  • 52
    • 79952135473 scopus 로고    scopus 로고
    • Trial: Mesenchymal stem cells transplantation in end stage liver disease
    • El-Ansary M, Mogawer S, Abdel-Aziz I, et al. Trial: mesenchymal stem cells transplantation in end stage liver disease. Stem Cell 2010;1(2):22-33
    • (2010) Stem Cell , vol.1 , Issue.2 , pp. 22-33
    • El-Ansary, M.1    Mogawer, S.2    Abdel-Aziz, I.3
  • 53
    • 77950858200 scopus 로고    scopus 로고
    • Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase i clinical trial
    • Mazzini L, Ferrero I, Luparello V, Rustichelli D. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial. Exp Neurol 2010;223(1):229-37
    • (2010) Exp Neurol , vol.223 , Issue.1 , pp. 229-237
    • Mazzini, L.1    Ferrero, I.2    Luparello, V.3    Rustichelli, D.4
  • 54
    • 77957964299 scopus 로고    scopus 로고
    • Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis
    • Karussis D, Karageorgiou C, Vaknin-Dembinsky A, et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol 2010;67(10):1187-94
    • (2010) Arch Neurol , vol.67 , Issue.10 , pp. 1187-1194
    • Karussis, D.1    Karageorgiou, C.2    Vaknin-Dembinsky, A.3
  • 55
    • 84876584274 scopus 로고    scopus 로고
    • Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: An open label study
    • Bonab MM, Sahraian MA, Aghsaie A, et al. Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study. Curr Stem Cell Res Ther 2012; 7(6):407-14
    • (2012) Curr Stem Cell Res Ther , vol.7 , Issue.6 , pp. 407-414
    • Bonab, M.M.1    Sahraian, M.A.2    Aghsaie, A.3
  • 56
    • 34249056207 scopus 로고    scopus 로고
    • Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study
    • Bonab MM, Yazdanbakhsh S, Lotfi J, et al. Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study. Iran J Immunol 2007;4(1):50-7
    • (2007) Iran J Immunol , vol.4 , Issue.1 , pp. 50-57
    • Bonab, M.M.1    Yazdanbakhsh, S.2    Lotfi, J.3
  • 57
    • 84855552728 scopus 로고    scopus 로고
    • Multipotent mesenchymal stromal cells for the prophylaxis of acute graft-versus-host disease-A phase II study
    • Kuzmina LA, Petinati NA, Parovichnikova EN, et al. Multipotent mesenchymal stromal cells for the prophylaxis of acute graft-versus-host disease-A phase II study. Stem Cells Int 2012;2012:968213
    • (2012) Stem Cells Int , vol.2012 , pp. 968213
    • Kuzmina, L.A.1    Petinati, N.A.2    Parovichnikova, E.N.3
  • 58
    • 84865572084 scopus 로고    scopus 로고
    • Phase II Trial: Undifferentiated Versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis
    • El-Ansary M, Abdel-Aziz I, Mogawer S, et al. Phase II Trial: undifferentiated Versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis. Stem Cell Rev Rep 2012;8(3):972-81
    • (2012) Stem Cell Rev Rep , vol.8 , Issue.3 , pp. 972-981
    • El-Ansary, M.1    Abdel-Aziz, I.2    Mogawer, S.3
  • 59
    • 84856023693 scopus 로고    scopus 로고
    • Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: An open-label phase 2a proof-of-concept study
    • Connick P, Kolappan M, Crawley C, et al. Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol 2012;11(2):150-6
    • (2012) Lancet Neurol , vol.11 , Issue.2 , pp. 150-156
    • Connick, P.1    Kolappan, M.2    Crawley, C.3
  • 60
    • 77956651196 scopus 로고    scopus 로고
    • Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: A pilot study
    • Yamout B, Hourani R, Salti H, et al. Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study. J Neuroimmunol 2010;227(1-2):185-9
    • (2010) J Neuroimmunol , vol.227 , Issue.1-2 , pp. 185-189
    • Yamout, B.1    Hourani, R.2    Salti, H.3
  • 61
    • 84876367679 scopus 로고    scopus 로고
    • Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant Crohn's disease: A phase 1 study
    • Mayer L, Pandak WM, Melmed GY, et al. Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant Crohn's disease: a phase 1 study. Inflamm Bowel Dis 2013; 19(4):754-60
    • (2013) Inflamm Bowel Dis , vol.19 , Issue.4 , pp. 754-760
    • Mayer, L.1    Pandak, W.M.2    Melmed, G.Y.3
  • 62
    • 79959422515 scopus 로고    scopus 로고
    • Cotransplantation of adipose tissue-derived insulin-secreting mesenchymal stem cells and hematopoietic stem cells: A novel therapy for insulin-dependent diabetes mellitus
    • Trivedi HL, Vanikar AV, Dave SD, Thakkar UG. Cotransplantation of adipose tissue-derived insulin-secreting mesenchymal stem cells and hematopoietic stem cells: A novel therapy for insulin-dependent diabetes mellitus. Stem Cells Intl 2010;2010:582382
    • (2010) Stem Cells Intl , vol.2010 , pp. 582382
    • Trivedi, H.L.1    Vanikar, A.V.2    Dave, S.D.3    Thakkar, U.G.4
  • 63
    • 84863338204 scopus 로고    scopus 로고
    • Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: A randomized controlled trial
    • Tan J, Wu W, Xu X, et al. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. J Am Med Assoc 2012;307(11):1169-77
    • (2012) J Am Med Assoc , vol.307 , Issue.11 , pp. 1169-1177
    • Tan, J.1    Wu, W.2    Xu, X.3
  • 64
    • 84862696059 scopus 로고    scopus 로고
    • Mesenchymal stromal cell therapy for steroid-refractory acute and chronic graft versus host disease: A phase 1 study
    • Herrmann R, Sturm M, Shaw K, et al. Mesenchymal stromal cell therapy for steroid-refractory acute and chronic graft versus host disease: a phase 1 study. Int J Hematol 2012;95(2):182-8
    • (2012) Int J Hematol , vol.95 , Issue.2 , pp. 182-188
    • Herrmann, R.1    Sturm, M.2    Shaw, K.3
  • 65
    • 77955451557 scopus 로고    scopus 로고
    • Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: A pilot clinical study
    • Liang J, Zhang HY, Hua BZ, et al. Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis 2010;69(8):1423-9
    • (2010) Ann Rheum Dis , vol.69 , Issue.8 , pp. 1423-1429
    • Liang, J.1    Zhang, H.Y.2    Hua, B.Z.3
  • 66
    • 77955361735 scopus 로고    scopus 로고
    • Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus
    • Sun L, Wang D, Liang J, et al. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum 2010;62(8): 2467-75
    • (2010) Arthritis Rheum , vol.62 , Issue.8 , pp. 2467-2475
    • Sun, L.1    Wang, D.2    Liang, J.3
  • 67
    • 84875468183 scopus 로고    scopus 로고
    • The mesenchymal stromal cells dilemma-does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road
    • Galipeau J. The mesenchymal stromal cells dilemma-does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road? Cytotherapy 2013;15(1):2-8
    • (2013) Cytotherapy , vol.15 , Issue.1 , pp. 2-8
    • Galipeau, J.1
  • 75
    • 84898996784 scopus 로고    scopus 로고
    • Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: Correlation of biological markers with clinical responses
    • Yin F, Battiwalla M, Ito S, et al. Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responses. Stem Cells 2014;32(5):1278-88
    • (2014) Stem Cells , vol.32 , Issue.5 , pp. 1278-1288
    • Yin, F.1    Battiwalla, M.2    Ito, S.3
  • 76
    • 60349129494 scopus 로고    scopus 로고
    • Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium
    • von Bonin M, Stolzel F, Goedecke A, et al. Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant 2009;43(3):245-51
    • (2009) Bone Marrow Transplant , vol.43 , Issue.3 , pp. 245-251
    • Von Bonin, M.1    Stolzel, F.2    Goedecke, A.3
  • 77
    • 84906858055 scopus 로고    scopus 로고
    • Alteration of naive and memory B-cell subset in chronic graft-versus-host disease patients after treatment with mesenchymal stromal cells
    • Peng Y, Chen X, Liu Q, et al. Alteration of naive and memory B-cell subset in chronic graft-versus-host disease patients after treatment with mesenchymal stromal cells. Stem Cells Transl Med 2014;3(9):1023-31
    • (2014) Stem Cells Transl Med , vol.3 , Issue.9 , pp. 1023-1031
    • Peng, Y.1    Chen, X.2    Liu, Q.3
  • 78
    • 78650208987 scopus 로고    scopus 로고
    • Mesenchymal stem cell as salvage treatment for refractory chronic GVHD
    • Weng JY, Du X, Geng SX, et al. Mesenchymal stem cell as salvage treatment for refractory chronic GVHD. Bone Marrow Transplant 2010;45(12):1732-40
    • (2010) Bone Marrow Transplant , vol.45 , Issue.12 , pp. 1732-1740
    • Weng, J.Y.1    Du, X.2    Geng, S.X.3
  • 79
    • 79959932280 scopus 로고    scopus 로고
    • Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: Results of a phase I/II clinical trial
    • Perez-Simon JA, Lopez-Villar O, Andreu EJ, et al. Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial. Haematologica 2011;96(7):1072-6
    • (2011) Haematologica , vol.96 , Issue.7 , pp. 1072-1076
    • Perez-Simon, J.A.1    Lopez-Villar, O.2    Andreu, E.J.3
  • 80
    • 77953603837 scopus 로고    scopus 로고
    • Cotransplantation of HLA-identical mesenchymal stem cells and hematopoietic stem cells in Chinese patients with hematologic diseases
    • Zhang X, Li JY, Cao K, et al. Cotransplantation of HLA-identical mesenchymal stem cells and hematopoietic stem cells in Chinese patients with hematologic diseases. Int J Lab Hematol 2010;32(2):256-64
    • (2010) Int J Lab Hematol , vol.32 , Issue.2 , pp. 256-264
    • Zhang, X.1    Li, J.Y.2    Cao, K.3
  • 81
    • 84867810334 scopus 로고    scopus 로고
    • Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome
    • Xu J, Wang D, Liu D, et al. Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome. Blood 2012;120(15):3142-51
    • (2012) Blood , vol.120 , Issue.15 , pp. 3142-3151
    • Xu, J.1    Wang, D.2    Liu, D.3
  • 82
    • 84919354336 scopus 로고    scopus 로고
    • Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy
    • Gu F, Wang D, Zhang H, et al. Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy. Clin Rheumatol 2014;33(11):1611-19
    • (2014) Clin Rheumatol , vol.33 , Issue.11 , pp. 1611-1619
    • Gu, F.1    Wang, D.2    Zhang, H.3
  • 83
    • 84879160785 scopus 로고    scopus 로고
    • Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience
    • Wang D, Zhang H, Liang J, et al. Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience. Cell Transplant 2013;22(12): 2267-77
    • (2013) Cell Transplant , vol.22 , Issue.12 , pp. 2267-2277
    • Wang, D.1    Zhang, H.2    Liang, J.3
  • 84
    • 84865853720 scopus 로고    scopus 로고
    • Mesenchymal stem cells are a rescue approach for recovery of deteriorating kidney function
    • El-Ansary M, Saadi G, Abd El-Hamid SM. Mesenchymal stem cells are a rescue approach for recovery of deteriorating kidney function. Nephrology 2012;17(7): 650-7
    • (2012) Nephrology , vol.17 , Issue.7 , pp. 650-657
    • El-Ansary, M.1    Saadi, G.2    Abd El-Hamid, S.M.3
  • 85
    • 84864948206 scopus 로고    scopus 로고
    • Double allogenic mesenchymal stem cells transplantations could not enhance therapeutic effect compared with single transplantation in systemic lupus erythematosus
    • Wang D, Akiyama K, Zhang H, et al. Double allogenic mesenchymal stem cells transplantations could not enhance therapeutic effect compared with single transplantation in systemic lupus erythematosus. Clin Dev Immunol 2012;2012:273291
    • (2012) Clin Dev Immunol , vol.2012 , pp. 273291
    • Wang, D.1    Akiyama, K.2    Zhang, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.